Brand-name drug makers are striking more deals with generic rivals to restrict the introduction of cheaper generic drugs, antitrust authorities said on Monday.shocking
Brand-name drug makers are striking more deals with generic rivals to restrict the introduction of cheaper generic drugs, antitrust authorities said on Monday.
No comments:
Post a Comment